494 related articles for article (PubMed ID: 33468109)
1. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.
Wen J; Chen W; Zhu Y; Zhang P
BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109
[TBL] [Abstract][Full Text] [Related]
2. Receipt of brachytherapy is an independent predictor of survival in glioblastoma in the Surveillance, Epidemiology, and End Results database.
Bartek J; Alattar AA; Dhawan S; Ma J; Koga T; Nakaji P; Dusenbery KE; Chen CC
J Neurooncol; 2019 Oct; 145(1):75-83. PubMed ID: 31471790
[TBL] [Abstract][Full Text] [Related]
3. The impact of surgery on the efficacy of adjuvant therapy in glioblastoma multiforme.
Brzozowska A; Toruń A; Mazurkiewicz M
Adv Clin Exp Med; 2015; 24(2):279-87. PubMed ID: 25931361
[TBL] [Abstract][Full Text] [Related]
4. Primary glioblastoma multiforme in younger patients: a single-institution experience.
Ulutin C; Fayda M; Aksu G; Cetinayak O; Kuzhan O; Ors F; Beyzadeoglu M
Tumori; 2006; 92(5):407-11. PubMed ID: 17168433
[TBL] [Abstract][Full Text] [Related]
5. Patient and treatment factors associated with survival among adult glioblastoma patients: A USA population-based study from 2000-2010.
Pan IW; Ferguson SD; Lam S
J Clin Neurosci; 2015 Oct; 22(10):1575-81. PubMed ID: 26122381
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Factors and Treatment Patterns in the Management of Giant Cell Glioblastoma.
Jin MC; Wu A; Xiang M; Azad TD; Soltys SG; Li G; Pollom EL
World Neurosurg; 2019 Aug; 128():e217-e224. PubMed ID: 31009783
[TBL] [Abstract][Full Text] [Related]
7. Outcome of conventional treatment and prognostic factor in elderly glioblastoma patients.
Oh SW; Jee TK; Kong DS; Nam DH; Lee JI; Seol HJ
Acta Neurochir (Wien); 2014 Apr; 156(4):641-51. PubMed ID: 24553726
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Survival in Turkish Patients with Primary Glioblastoma.
Bilgin E; Duman BB; Altintas S; Cil T; Gezercan Y; Okten AI
Turk Neurosurg; 2021; 31(4):641-653. PubMed ID: 33759174
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
Shields LB; Shelton BJ; Shearer AJ; Chen L; Sun DA; Parsons S; Bourne TD; LaRocca R; Spalding AC
Radiat Oncol; 2015 Oct; 10():222. PubMed ID: 26520780
[TBL] [Abstract][Full Text] [Related]
10. Patient and treatment factors associated with survival among pediatric glioblastoma patients: A Surveillance, Epidemiology, and End Results study.
Lam S; Lin Y; Zinn P; Su J; Pan IW
J Clin Neurosci; 2018 Jan; 47():285-293. PubMed ID: 29102237
[TBL] [Abstract][Full Text] [Related]
11. Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study.
Zhu P; Du XL; Lu G; Zhu JJ
Oncotarget; 2017 Jul; 8(27):44015-44031. PubMed ID: 28467795
[TBL] [Abstract][Full Text] [Related]
12. Treatment and survival of patients harboring histological variants of glioblastoma.
Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
[TBL] [Abstract][Full Text] [Related]
13. Improved survival time trends for glioblastoma using the SEER 17 population-based registries.
Koshy M; Villano JL; Dolecek TA; Howard A; Mahmood U; Chmura SJ; Weichselbaum RR; McCarthy BJ
J Neurooncol; 2012 Mar; 107(1):207-12. PubMed ID: 21984115
[TBL] [Abstract][Full Text] [Related]
14. Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme.
Kim YH; Kim T; Joo JD; Han JH; Kim YJ; Kim IA; Yun CH; Kim CY
Cancer; 2015 Sep; 121(17):2926-32. PubMed ID: 25975354
[TBL] [Abstract][Full Text] [Related]
15. Comparative Analysis of Survival Outcomes and Prognostic Factors of Supratentorial versus Cerebellar Glioblastoma in the Elderly: Does Location Really Matter?
Chandra A; Lopez-Rivera V; Dono A; Brandel MG; Lewis C; O'Connor KP; Sheth SA; Ballester LY; Aghi MK; Esquenazi Y
World Neurosurg; 2021 Feb; 146():e755-e767. PubMed ID: 33171326
[TBL] [Abstract][Full Text] [Related]
16. Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiforme.
Kole AJ; Park HS; Yeboa DN; Rutter CE; Corso CD; Aneja S; Lester-Coll NH; Mancini BR; Knisely JP; Yu JB
Cancer; 2016 Aug; 122(15):2364-70. PubMed ID: 27172136
[TBL] [Abstract][Full Text] [Related]
17. Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study.
Al-Husseini MJ; Saad AM; El-Shewy KM; Nissan NE; Gad MM; Alzuabi MA; Samir Alfaar A
Int J Neurosci; 2019 May; 129(5):447-454. PubMed ID: 30366515
[TBL] [Abstract][Full Text] [Related]
18. Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo.
Ellingson BM; Abrey LE; Garcia J; Chinot O; Wick W; Saran F; Nishikawa R; Henriksson R; Mason WP; Harris RJ; Leu K; Woodworth DC; Mehta A; Raymond C; Chakhoyan A; Pope WB; Cloughesy TF
Neuro Oncol; 2018 Oct; 20(11):1525-1535. PubMed ID: 29897562
[TBL] [Abstract][Full Text] [Related]
19. Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis.
Kozak KR; Moody JS
Neuro Oncol; 2009 Dec; 11(6):833-41. PubMed ID: 19332771
[TBL] [Abstract][Full Text] [Related]
20. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
